BMY trailing returns
Bristol-Myers Squibb Company's 10-year annualized return is +2.3% per year (+25.2% cumulative). How Bristol-Myers Squibb Company (BMY) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through July 2, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-07-02. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | +3.0% | |
| 1 week | — | +4.9% | |
| 1 month | — | +6.7% | |
| YTD | — | +10.1% | |
| 1 year | +28.4% | +28.4% | |
| 5 years | +1.1% | +5.7% | |
| 10 years | +2.3% | +25.2% | |
| 20 years | +9.3% | +488.3% | |
| Since inception (1972) | +9.2% | +11622.1% |
Growth of BMY#
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-07-02). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from BMY's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ
- What is Bristol-Myers Squibb Company's 10-year return?
- Over the last 10 years, Bristol-Myers Squibb Company (BMY) returned about +2.3% a year annualized (+25.2% cumulative total return).
- What is Bristol-Myers Squibb Company's 20-year annualized return?
- Over the last 20 years, Bristol-Myers Squibb Company (BMY) compounded at about +9.3% a year (+488.3% cumulative).
- What is Bristol-Myers Squibb Company's return since inception?
- Since 1972, Bristol-Myers Squibb Company (BMY) has compounded at about +9.2% a year — +11622.1% in total.